These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

57 related articles for article (PubMed ID: 3497613)

  • 21. Immunotherapy of cancer with lymphokine-activated killer cells and recombinant interleukin-2.
    Rosenberg SA; Mulé JJ
    Surgery; 1985 Sep; 98(3):437-44. PubMed ID: 3898451
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Tumor growth suppression by a mouse/human chimeric anti-CEA antibody and lymphokine-activated killer cells in vitro and in SCID mouse xenograft model.
    Senba T; Kuroki M; Arakawa F; Yamamoto T; Kuwahara M; Haruno M; Ikeda S; Matsuoka Y
    Anticancer Res; 1998; 18(1A):17-24. PubMed ID: 9568050
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Interleukin 2 protects hairy leukemic cells from lymphokine-activated killer cell-mediated cytotoxicity.
    Reiter Z; Taylor MW
    Cancer Res; 1993 Aug; 53(15):3555-60. PubMed ID: 7687924
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Systemic interleukin-2 and adoptive transfer of lymphokine-activated killer cells improves antibody-dependent cellular cytotoxicity in patients with relapsed B-cell lymphoma treated with rituximab.
    Berdeja JG; Hess A; Lucas DM; O'Donnell P; Ambinder RF; Diehl LF; Carter-Brookins D; Newton S; Flinn IW
    Clin Cancer Res; 2007 Apr; 13(8):2392-9. PubMed ID: 17438098
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Malignant pericardial effusion and cardiac tamponade in endometrial adenocarcinoma.
    Kheterpal P; Singh M; Mondul A; Dharmarajan L; Soni A
    Gynecol Oncol; 2001 Oct; 83(1):143-5. PubMed ID: 11585427
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A phase III randomized study of interleukin-2 lymphokine-activated killer cell immunotherapy combined with chemotherapy or radiotherapy after curative or noncurative resection of primary lung carcinoma.
    Kimura H; Yamaguchi Y
    Cancer; 1997 Jul; 80(1):42-9. PubMed ID: 9210707
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A new strategy using autologous dendritic cells and lymphokine-activated killer cells for cancer immunotherapy: efficient maturation of DCs by co-culture with LAK cells in vitro.
    Yano Y; Ueda Y; Itoh T; Fuji N; Okugawa K; Naito K; Imura K; Kohara J; Hayashi T; Nakane K; Matsuura Y; Kawai K; Yamagishi H
    Oncol Rep; 2006 Jul; 16(1):147-52. PubMed ID: 16786138
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [LAK cells and cancer].
    Taguchi T; Kimoto Y
    Gan To Kagaku Ryoho; 1986 Dec; 13(12):3327-33. PubMed ID: 3539024
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Recurrent autoreactive pericardial effusion. Impact of an aetiological classification of pericarditis].
    Maisch B; Karatolios K; Pankuweit S
    Dtsch Med Wochenschr; 2006 Sep; 131(39):2143-6. PubMed ID: 16991029
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Interleukin-12 synergizes with interleukin-2 to generate lymphokine-activated killer activity in peripheral blood mononuclear cells cultured in ovarian cancer ascitic fluid.
    Barton DP; Blanchard DK; Duan C; Roberts WS; Cavanagh D; DeCesare S; Djeu JY
    J Soc Gynecol Investig; 1995; 2(6):762-71. PubMed ID: 9420887
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Effectiveness of treatment with transfer of autologous or allogenic LAK cells combined with rIL-2 in 121 patients with malignant pleural effusion].
    Liu X
    Zhonghua Zhong Liu Za Zhi; 1993 May; 15(3):205-8. PubMed ID: 8261867
    [TBL] [Abstract][Full Text] [Related]  

  • 32. IL-2-based immunotherapy after autologous transplantation for lymphoma and breast cancer induces immune activation and cytokine release: a phase I/II trial.
    Burns LJ; Weisdorf DJ; DeFor TE; Vesole DH; Repka TL; Blazar BR; Burger SR; Panoskaltsis-Mortari A; Keever-Taylor CA; Zhang MJ; Miller JS
    Bone Marrow Transplant; 2003 Jul; 32(2):177-86. PubMed ID: 12838283
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Immunotherapy of cancer by systemic administration of lymphoid cells plus interleukin-2.
    Rosenberg SA
    J Biol Response Mod; 1984 Oct; 3(5):501-11. PubMed ID: 6389777
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Cardiac tamponade caused by diffuse pericardial mesothelioma].
    Oshima K; Endo S; Sohara Y; Murayama F; Yamaguchi T; Fuse K; Ishii Y; Kitamura S; Kuriki K; Saito K
    Nihon Kyobu Shikkan Gakkai Zasshi; 1997 Jul; 35(7):822-5. PubMed ID: 9341291
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Antimetastasis effect of lymphokine-activated killer (LAK) cells on fibrosarcoma in WKA rats].
    Wang ZH; Li XB; Yao XD; Ba DN
    Zhonghua Zhong Liu Za Zhi; 1986 Nov; 8(6):421-3. PubMed ID: 3495421
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Lymphokine-activated killer cells: culture conditions for the generation of maximal in vitro cytotoxicity in cells from normal donors.
    Beckner SK; Maluish AE; Longo DL
    Cancer Res; 1987 Oct; 47(20):5504-8. PubMed ID: 3498534
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [A case of metastatic breast carcinoma with cardiac tamponade and pleural effusion showing long survival by local treatment combined with systemic chemotherapy].
    Shimizu M; Sakauchi G; Mukai S; Sakamoto T
    Gan To Kagaku Ryoho; 1992 Aug; 19(10 Suppl):1636-9. PubMed ID: 1530323
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [A case of cardiac tamponade due to pericarditis carcinomatosa of breast cancer successfully treated via pericardiocentesis and systemic chemo-endocrine therapy].
    Satoh E; Ebuchi M; Suzuki K; Uehira D; Ono S; Yonekura K; Murakata A; Tanami H; Maruyama S; Sugano N; Maruyama M; Matsumoto J; Sakoma T
    Gan To Kagaku Ryoho; 2014 Nov; 41(12):1895-6. PubMed ID: 25731367
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Treatment of malignant ascites with allogeneic and autologous lymphokine-activated killer cells.
    Kamada M; Sakamoto Y; Furumoto H; Mori K; Daitoh T; Irahara M; Aono T; Nii A; Yanagawa H; Sone S
    Gynecol Oncol; 1989 Jul; 34(1):34-7. PubMed ID: 2786830
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [The effect of LAK cells on experimental peritonitis carcinomatosa].
    Nojiri S; Takago Y; Sasakawa Y; Kanizawa Y; Ueno Y; Niitsu Y; Urushuzaki I
    Nihon Shokakibyo Gakkai Zasshi; 1986 Jun; 83(6):1233. PubMed ID: 3489852
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 3.